The levels of MCP-1 were higher in fibroblasts from COPD patients compared to control subjects at normoxic (p = 0.007) and hypoxic (p = 0.022) conditions (Fig. 4c). Here, CCL2 is linked to chronic obstructive pulmonary disease.